Medicine
Orabloc 72 mg/18 mcg per 1.8 mL injection
Orabloc 72 mg/18 mcg per 1.8 mL injection is a prescription medicine containing Articaine and Epinephrine for submucosal use, marketed by Pierrel, with its source record on the US FDA register. It is available on request for export supply from India to licensed hospitals, importers and physicians.
Availability
Export supply from India to licensed buyers
Typical lead time
On request
Counted from payment and complete documents
Shipping
Ambient
Do not freeze. Store at 20° to 25°C (68° to 77°F), excursions permitted…
Key facts
- Active ingredient (INN)
- Articaine and Epinephrine
- Brand
- Orabloc
- Strength
- 72 mg/18 mcg per 1.8 mL
- Dosage form
- Injection
- Route
- Submucosal
- Packs
- 100 cartridges of 1.8 mL, 50 cartridges of 1.8 mL
- Marketing authorisation holder
- Pierrel
- Manufacturer
- Pierrel
- Origin register
- US FDA, United States
- Storage
- Do not freeze. Store at 20° to 25°C (68° to 77°F), excursions permitted between 15° to 30°C (59° to 86°F). Protect from light.
- Cold chain
- Not required on record
- Prescription status
- Prescription only
- Controlled substance
- Not recorded as controlled
- HS code (indicative)
- 3004.90Indicative only. Your customs broker confirms the final tariff code.
- Marketing category
- marketed
- Marketed since
- 1 March 2011
- Identifiers
- RxCUI 1091068, 1091072, 1658966 +1DailyMed set ID d18424f0-a691-11dd-ad8b-0800200c9a66NDC 45146-110Application NDA022466
Record updated 12 November 2026
Documents available
Documents that can be provided with this medicine. Your regulator may ask for more, and the quote lists the full set.
No document list is recorded for this medicine yet. Tell us which documents your regulator needs (for example a CoA, COPP or GMP certificate) when you request a quote.
Packs
Status by register
Where this medicine is registered, from the source record and the regulator data we hold. Ask us about a country that is not listed.
| Register | Status | Source |
|---|---|---|
| US FDA | Listed, marketed | Source record for this pageChecked 12 November 2026 |
| US FDA | First approved 3 April 2000 | Drugs@FDA |
| EU (EMA) | Not recorded | — |
| India (CDSCO) | Not yet confirmed against CDSCO approval lists | — |
| United States | Registered | US FDA (NDC directory, openFDA)Checked 12 November 2026 |
Import route
Pick the destination country to see the legal import route, who applies and typical timelines, from our import guide for that country.
Import guides are available for 25 countries. Pick one to see its route summary.
BrazilColombiaEgyptEthiopiaGhanaIraqKazakhstanKenyaAll import guides
Alternatives
Other makers and brands of Articaine and Epinephrine 72 mg/18 mcg per 1.8 mL injection.
Other strengths and forms of Articaine and Epinephrine
Clinical summary
Articaine and Epinephrine is a fixed-dose combination of an amide local anesthetic, a catecholamine and an alpha-adrenergic agonist. It is available as injection for submucosal use. MedsAcross supplies Articaine and Epinephrine for export from India to licensed hospitals, importers and physicians acting for named patients, with the documents each country requires.
Information from the US FDA prescribing information, retrieved 12 November 2026. Not yet medically reviewed.How we review
Read about Articaine and EpinephrineFor healthcare professionals and buyers. This is not medical advice. Treatment decisions belong to the prescriber.
Data sources
- DailyMed label record · Checked 12 November 2026
- Articaine Hydrochloride and Epinephrine prescribing information (Novocol Pharmaceutical of Canada) · U.S. National Library of Medicine, DailyMed
Need Orabloc 72 mg/18 mcg per 1.8 mL injection for your hospital or patient?
Send one request with the destination country and quantity. We confirm availability, lead time and the documents your regulator needs.